CEO is currently on road show - Brisbane, Sydney, Melbourne.
Benlysta has minimal therapeutic effect and sales are slowing. The space is wide open. If we get positive results in Lupus, we have a whole range of auto-immune conditions open to this drug. The potential is absolutely huge. And that is without considering the potential of the asthma (and other lung condition)drug Nadilol. Put the two together and the potential is mind blowing. And we appear to have really competent, grown-up management, at last.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $11.01M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $36.56K | 283.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 247400 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 119856 | 1 |
View Market Depth
| Last trade - 15.40pm 23/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |